这项研究还发现,没有服用药片的病人中,62%有头疼症状,与之相比,得到治疗的其他三组中,只有不到50%的病人有头疼症状。
The study also found 62% of patients who didn't receive pills reported headaches compared with less than 50% of patients in the other three treatment groups.
经过26周的治疗,联合用药的病人中有57%获得缓解,与之相比,在单用英夫利昔单抗组中只有44%而单用硫唑嘌呤组中只有30%得到缓解。
After 26 weeks of treatment, patients getting the combination had a 57% chance of disease remission, compared to 44% of those getting Remicade alone and to 30% of those getting azathioprine alone.
结果:联合用药的两组与甘利欣单独治疗组比较均出现显著性差异。
Results Two groups of united medication compare with group of sole medication. it presented striking difference.
对照组仅用药物治疗。
结论治疗组用药方案优于对照组,安全度大,是临床一线治疗脑梗塞合并高血压病值得推广的方案。
ConclusionThe scheme of treatment group is better than the control group. It is safe and worth spreading in the clinic on cerebral infarction with hypertension.
分别测定治疗剂量、中毒剂量、致死剂量组小鼠在用药一段时间后的肝肾功能,并进行组织病理学检查。
Hepatic and renal functions, and tissue biopsy were measured in rats with therapeutic, toxic and lethiferous dose treatment after a period of time.
中西医结合组在西医组用药基础上加用自拟紫癜肾炎方治疗。
Except routine treatment of western medicine, herbal recipe on Henoch-Schnlein purpura nephritis was employed in the observation group.
综合治疗组为药物联合康复训练,为期12周,对照组单纯使用药物。
The patients of combined therapy group were treated by antipsychotic medication and rehabilitation-training for 12weeks.
在总治疗时间方面,通过对四组用药的疗程分析,发现葛根素用药组疗程长于其他各组。
In total treatment time, the four groups through the course of medication, found that puerarin drug treatment group than other groups.
结果第一组用药物治疗效果一般,患者需要长期的使用药物控制高血压病。
The results of the first group of drug treatment in general, patients need long-term use of medications to control hypertension.
结果用药后吡哌酸锌软膏治疗组创面来愈面积明显小于对照组。
Results The results show the unhealing area treated by zinc pipemidate ointment was obviously smaller than that of the controls.
方法利用药物维持治疗工作组制定的随访调查表对门诊在治一年的患者进行调查分析。
Methods To analysis of the patients who is out-patient follow-up questionnaire a year by use of drug maintenance treatment developed by the Working Group on.
衰老模型实验:SD大鼠随机分为对照组、D-半乳糖组、正常用药组、溶媒对照组和药物治疗组。
SD rats were randomly assigned to five groups as follows: saline control group, D-galactose group, DHEA-treated normal group, vehicle control group and DHEA-treated senescent group.
治疗组用药过程中均未出现不良反应。
治疗组治疗后观察半年未见复发,与服用药物前相比较复发时间明显延长,治疗前后复发时间间隔比较存在显著差异。
There is no recurrent cases in the treating group during the six-month observation, which has the significant difference comparing with that of the group before having this drug.
说明用药治疗后,脉痹通组病理损害恢复较显著。
After treatment of administration, the pathological damages in the Maibitong group had comparatively obvious recovery.
方法将DM大鼠随机分为西洛他唑治疗组和DM组,用药8周后检测两组血糖、体质量、糖化血红蛋白、心脏重量指数,观察其心肌细胞超微结构变化。
DM rats were randomly divided into cilostazol group and DM group. 8 weeks after treatment, blood glucose, body weight, HbA1c, cardiac weight index and ultrastructure of myocardiocyt were observed.
结果治疗组与对照组在用药天数、治疗效果及药物副反应方面差异有显著统计学意义(P<0.05)。
Results The treatment group had more significantly statistical difference(P< 0.05) at the aspects of medication days, treatment efficacy and side effects in contrast to the control group.
结果从两组治疗方法的平均疼痛消失时间、治疗后用药天数及疗程均无明显差异。
Results The average time of pain delivery, the days of drug administration after treatment and the course in the 2 groups were of no obvious differences.
结果:用药4周后,治愈率、创面愈合时间、创面缩小率以及组织学观察治疗组均优于对照组。
Results: After 4 weeks, better results were observed in cure rate, wound healing time, wound area reduced rate and histological changes in treatment group than those in control group.
治疗组联合用药对临床症状体征的改善优于中药组和西药组。
The treatment group is superior to the TCM group and WM group on improving the clinical symptoms and signs (P0.05).
方法:将40例脑卒中下肢肌张力增高的患者分为治疗组和对照组,治疗组应用针刺治疗,对照组应用康复运动疗法,两组病例数及用药均相同。
Methods: 40 patients were randomly divided into two groups: the treating group treated by acupuncture , and the control group treated by motor programme method.
预防性用药组中,98%没有出现痉挛;治疗性用药组中,2%为控制癫痫发作无效。
Among groups with prophylactic administration, 98% did not develop convulsion and among groups with therapeutic administration, 2% was ineffective to control seizure.
联合治疗组使用丹参、川芎合用药+常规治疗。
In combining treatment group, Salvia Miltiorrhiza Ligustrazine and routine treatment were used.
联合治疗组使用丹参、川芎合用药+常规治疗。
In combining treatment group, Salvia Miltiorrhiza Ligustrazine and routine treatment were used.
应用推荐